Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v23-FR Version v9-EN
Language French English
Date Updated 2020-02-06 2019-08-01
Drug Identification Number 02279444 02279444
Brand name GAMMAGARD LIQUID GAMMAGARD LIQUID
Common or Proper name GAMMAGARD LIQUID, Immunoglobulin Intravenous GAMMAGARD LIQUID, Immunoglobulin Intravenous
Company Name TAKEDA CANADA INC TAKEDA CANADA INC
Ingredients IMMUNOGLOBULIN IMMUNOGLOBULIN
Strength(s) 10% 10%
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL
ATC code J06BA J06BA
ATC description IMMUNOGLOBULINS IMMUNOGLOBULINS
Reason for shortage Other (Please describe in comments) Shortage of an active ingredient.
Anticipated start date 2019-07-31 2019-07-31
Actual start date 2019-07-31 2019-07-31
Estimated end date 2019-09-30 2019-09-30
Actual end date 2020-01-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Temporary shortage in some product size formats. Resolved as of 13Jan2020 Temporary shortage in some product size formats. 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL
Health Canada comments